# Trade Mark Journal No.2025/047 21 November 2025

## WO0000001872533 (5)

Office of origin: United States of America

Date of International Registration:25 July 2025
Date of designation in the UK: 16 October 2025

Class 5
  Pharmaceuticals for the treatment of cancer.

Eagle Pharmaceuticals Inc.

Representative: John M. Mueller Baker & Hostetler LLP, 312 Walnut Street, Suite 3200, Cincinnati OH 45202, UNITED STATES OF AMERICA